← Back
$BOLT All transactions

Bolt Biotherapeutics, Inc.

A

$ Value

Shares

1,000

Price

Filed

Dec 16

Insider

Name

Dupont Jakob

Title

CIK

0001553335

Roles

Director

Transaction Details

Transaction Date

2025-12-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,000

Footnotes

For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following September 3, 2024; provided, however that the option will vest in full upon a change in control. | The reporting person agreed to cancellation of an option granted on September 3, 2024, in exchange for a new option having a lower exercise price. | The option is fully vested and exercisable. | The reporting person agreed to cancellation of an option granted on September 3, 2024, in exchange for a new option having a lower exercise price. | The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price. | The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer. | The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price.

Filing Info

Accession No.

0001193125-25-321156

Form Type

4

Issuer CIK

0001641281

Dupont Jakob's History

Date Ticker Type Value
2026-03-24 PYXS A $0
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-12-12 BOLT A
2025-12-12 BOLT D
2025-05-27 BOLT A $0

Other Insiders at BOLT (90d)

Insider Bought Sold Last
Quinn William P.
President, CEO and CFO
$576 2026-01-28
Nemec Sarah
Senior VP, Finance and PAO
$576 2026-01-28
Yonehiro Grant
Chief Operating Officer
2026-01-28